Hospital
Chi ST. Luke's Health Baylor College of Medicine Medical Center
Chi ST. Luke's Health Baylor College of Medicine Medical Center was paid $3.30M by Medicaid between Sep 2019 and Dec 2024, across 81 billing codes. Its largest line is 99283, emergency room visit (moderate) — 44% of everything it billed.
33Billing provider infoCHI ST. LUKE'S HEALTH BAYLOR COLLEGE OF MEDICINE MEDICAL CENTER
HOUSTON, TX 77030
HOUSTON, TX 77030
33aNPI1184622847assigned 07/07/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.30M
24GClaims80,168
24DCodes billed81
24AFirst – last monthSep 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#42 of 109
Median peer was paid$1.15M
This provider vs. median2.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 55 | $268.16 | |
| 2020 | 2,498 | $154K | |
| 2021 | 19,660 | $788K | |
| 2022 | 25,757 | $1.05M | |
| 2023 | 20,379 | $968K | |
| 2024incomplete | 11,819 | $342K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 44% | 11,675 | 11,093 | $1.45M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 2,394 | 2,151 | $996K |
| 80053 | Comprehensive metabolic panel | 5.7% | 4,956 | 3,367 | $187K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.0% | 738 | 650 | $133K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 8,241 | 5,825 | $65K |
| 80197 | 2.0% | 2,598 | 1,466 | $65K | |
| 82248 | 1.3% | 1,156 | 526 | $44K | |
| 81001 | 1.3% | 2,350 | 1,918 | $42K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 1,457 | 1,200 | $42K |
| 83735 | 1.2% | 3,023 | 1,925 | $39K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,301 | 2,433 | $30K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 676 | 635 | $26K |
69 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 277 | $22K |
| 84100 | <1% | 1,680 | $21K | |
| 87400 | <1% | 1,056 | $21K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 674 | $18K |
| 94010 | <1% | 60 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 345 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 143 | $7K |
| 0001A | <1% | 376 | $6K | |
| 86833 | <1% | 13 | $6K | |
| 86832 | <1% | 13 | $6K | |
| 81025 | <1% | 762 | $5K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,101 | $5K |
| 80076 | <1% | 716 | $4K | |
| 83880 | <1% | 642 | $4K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 130 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 58 | $3K |
| 71045 | Radiologic examination, chest; single view | <1% | 542 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,310 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 219 | $3K |
| 0002A | <1% | 233 | $3K | |
| 83970 | <1% | 50 | $3K | |
| 84484 | <1% | 1,044 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 298 | $2K |
| 87497 | <1% | 32 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 926 | $2K |
| 85610 | <1% | 1,628 | $1K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 31 | $1K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 14 | $902.48 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 315 | $825.85 |
| 83690 | <1% | 320 | $812.74 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 130 | $526.90 |
| 85730 | <1% | 488 | $499.09 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 84 | $496.93 |
| 86850 | <1% | 95 | $470.32 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 99 | $442.50 |
| 87081 | <1% | 31 | $441.93 | |
| 84702 | <1% | 51 | $412.21 | |
| 87807 | <1% | 16 | $297.77 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 54 | $253.62 |
| 82105 | <1% | 15 | $246.02 | |
| 82570 | <1% | 16 | $229.32 | |
| 82947 | <1% | 1,140 | $224.59 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 16 | $220.53 |
| 84156 | <1% | 16 | $219.71 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 547 | $177.93 |
| 99152 | <1% | 41 | $171.82 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 101 | $167.46 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 781 | $163.30 |
| 86828 | <1% | 15 | $106.76 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 338 | $58.54 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 483 | $53.02 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 699 | $47.76 |
| 86900 | <1% | 102 | $45.81 | |
| 86901 | <1% | 98 | $45.79 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 410 | $35.77 |
| 87186 | <1% | 12 | $34.89 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 15 | $30.72 |
| 87077 | <1% | 12 | $25.80 | |
| 83605 | <1% | 15 | $18.46 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 45 | $12.88 |
| 80061 | Lipid panel | <1% | 69 | $8.43 |
| A9270 | Non-covered item or service | 0% | 7,519 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 856 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 46 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 13 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 15 | $0.00 |
| 87799 | 0% | 31 | $0.00 | |
| 91300 | 0% | 60 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYOUNGBLOOD, ELIZABETH (PRESIDENT, CHIEF EXECUTIVE OFFICER)